The anti-PD-L1 CAR-NK, combined with anti-PD-1 and IL-15 super antagonist N-803, enhanced NK-cell cytotoxicity in a mouse oral cancer syngeneic model, while reducing T-cell exhaustion and stimulating T-cell responses through IL-15-induced IFNγ release. Here, IL15 is linked to lip and oral cavity carcinoma.